glp 1 molecular structure Full-length human GLP-1 receptor without orthosteric ligands Glucagon-like peptide 1 (7-36)amide |
Description
This triple action may reduce appetite, increase fullness, support blood sugar control and influence how the body uses energy
Seek medical attention right away if you still feel shaky, dizzy, nervous, irritated, confused, or weak after you have treated yourself for low blood sugar
doi: 10.1093/ajcn/83.2.260
Keep a realistic timeline for results in mind and prioritize stable blood sugar over rapid weight loss during transitions
Endocrinology 146, 37483756
N.RankinS
